Cargando…

Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease

BACKGROUND: Cardiopulmonary exercise testing (CPET), and its primary outcome of peak oxygen uptake (VO(2peak)), are acknowledged as biomarkers in the diagnostic and prognostic management of interstitial lung disease (ILD). However, the validity and repeatability of CPET in those with ILD has yet to...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomlinson, Owen W., Markham, Laura, Wollerton, Rebecca L., Knight, Bridget A., Duckworth, Anna, Gibbons, Michael A., Scotton, Chris J., Williams, Craig A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784077/
https://www.ncbi.nlm.nih.gov/pubmed/36550475
http://dx.doi.org/10.1186/s12890-022-02289-0
_version_ 1784857724682502144
author Tomlinson, Owen W.
Markham, Laura
Wollerton, Rebecca L.
Knight, Bridget A.
Duckworth, Anna
Gibbons, Michael A.
Scotton, Chris J.
Williams, Craig A.
author_facet Tomlinson, Owen W.
Markham, Laura
Wollerton, Rebecca L.
Knight, Bridget A.
Duckworth, Anna
Gibbons, Michael A.
Scotton, Chris J.
Williams, Craig A.
author_sort Tomlinson, Owen W.
collection PubMed
description BACKGROUND: Cardiopulmonary exercise testing (CPET), and its primary outcome of peak oxygen uptake (VO(2peak)), are acknowledged as biomarkers in the diagnostic and prognostic management of interstitial lung disease (ILD). However, the validity and repeatability of CPET in those with ILD has yet to be fully characterised, and this study fills this evidence gap. METHODS: Twenty-six people with ILD were recruited, and 21 successfully completed three CPETs. Of these, 17 completed two valid CPETs within a 3-month window, and 11 completed two valid CPETs within a 6-month window. Technical standards from the European Respiratory Society established validity, and repeatability was determined using mean change, intraclass correlation coefficient and typical error. RESULTS: Every participant (100%) who successfully exercised to volitional exhaustion produced a maximal, and therefore valid, CPET. Approximately 20% of participants presented with a plateau in VO(2), the primary criteria for establishing a maximal effort. The majority of participants otherwise presented with secondary criteria of respiratory exchange ratios in excess of 1.05, and maximal heart rates in excess of their predicted values. Repeatability analyses identified that the typical error (expressed as percent of coefficient of variation) was 20% over 3-months in those reaching volitional exhaustion. CONCLUSION: This work has, for the first time, fully characterised how patients with ILD respond to CPET in terms of primary and secondary verification criteria, and generated novel repeatability data that will prove useful in the assessment of disease progression, and future evaluation of therapeutic regimens where VO(2peak) is used as an outcome measure.
format Online
Article
Text
id pubmed-9784077
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97840772022-12-24 Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease Tomlinson, Owen W. Markham, Laura Wollerton, Rebecca L. Knight, Bridget A. Duckworth, Anna Gibbons, Michael A. Scotton, Chris J. Williams, Craig A. BMC Pulm Med Research BACKGROUND: Cardiopulmonary exercise testing (CPET), and its primary outcome of peak oxygen uptake (VO(2peak)), are acknowledged as biomarkers in the diagnostic and prognostic management of interstitial lung disease (ILD). However, the validity and repeatability of CPET in those with ILD has yet to be fully characterised, and this study fills this evidence gap. METHODS: Twenty-six people with ILD were recruited, and 21 successfully completed three CPETs. Of these, 17 completed two valid CPETs within a 3-month window, and 11 completed two valid CPETs within a 6-month window. Technical standards from the European Respiratory Society established validity, and repeatability was determined using mean change, intraclass correlation coefficient and typical error. RESULTS: Every participant (100%) who successfully exercised to volitional exhaustion produced a maximal, and therefore valid, CPET. Approximately 20% of participants presented with a plateau in VO(2), the primary criteria for establishing a maximal effort. The majority of participants otherwise presented with secondary criteria of respiratory exchange ratios in excess of 1.05, and maximal heart rates in excess of their predicted values. Repeatability analyses identified that the typical error (expressed as percent of coefficient of variation) was 20% over 3-months in those reaching volitional exhaustion. CONCLUSION: This work has, for the first time, fully characterised how patients with ILD respond to CPET in terms of primary and secondary verification criteria, and generated novel repeatability data that will prove useful in the assessment of disease progression, and future evaluation of therapeutic regimens where VO(2peak) is used as an outcome measure. BioMed Central 2022-12-22 /pmc/articles/PMC9784077/ /pubmed/36550475 http://dx.doi.org/10.1186/s12890-022-02289-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Tomlinson, Owen W.
Markham, Laura
Wollerton, Rebecca L.
Knight, Bridget A.
Duckworth, Anna
Gibbons, Michael A.
Scotton, Chris J.
Williams, Craig A.
Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease
title Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease
title_full Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease
title_fullStr Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease
title_full_unstemmed Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease
title_short Validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease
title_sort validity and repeatability of cardiopulmonary exercise testing in interstitial lung disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784077/
https://www.ncbi.nlm.nih.gov/pubmed/36550475
http://dx.doi.org/10.1186/s12890-022-02289-0
work_keys_str_mv AT tomlinsonowenw validityandrepeatabilityofcardiopulmonaryexercisetestingininterstitiallungdisease
AT markhamlaura validityandrepeatabilityofcardiopulmonaryexercisetestingininterstitiallungdisease
AT wollertonrebeccal validityandrepeatabilityofcardiopulmonaryexercisetestingininterstitiallungdisease
AT knightbridgeta validityandrepeatabilityofcardiopulmonaryexercisetestingininterstitiallungdisease
AT duckworthanna validityandrepeatabilityofcardiopulmonaryexercisetestingininterstitiallungdisease
AT gibbonsmichaela validityandrepeatabilityofcardiopulmonaryexercisetestingininterstitiallungdisease
AT scottonchrisj validityandrepeatabilityofcardiopulmonaryexercisetestingininterstitiallungdisease
AT williamscraiga validityandrepeatabilityofcardiopulmonaryexercisetestingininterstitiallungdisease